Compare PLOW & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLOW | MYGN |
|---|---|---|
| Founded | 1948 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 776.2M | 625.5M |
| IPO Year | 2010 | 1995 |
| Metric | PLOW | MYGN |
|---|---|---|
| Price | $33.47 | $6.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 12 |
| Target Price | ★ $39.00 | $11.82 |
| AVG Volume (30 Days) | 135.9K | ★ 910.3K |
| Earning Date | 11-03-2025 | 11-03-2025 |
| Dividend Yield | ★ 3.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | $615,064,000.00 | ★ $825,300,000.00 |
| Revenue This Year | $15.07 | $0.08 |
| Revenue Next Year | $10.40 | $5.28 |
| P/E Ratio | $19.08 | ★ N/A |
| Revenue Growth | ★ 9.99 | 0.21 |
| 52 Week Low | $21.30 | $3.76 |
| 52 Week High | $34.41 | $15.47 |
| Indicator | PLOW | MYGN |
|---|---|---|
| Relative Strength Index (RSI) | 57.84 | 39.01 |
| Support Level | $33.09 | $6.38 |
| Resistance Level | $34.08 | $6.89 |
| Average True Range (ATR) | 0.69 | 0.29 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 60.24 | 5.71 |
Douglas Dynamics Inc is a manufacturer and upfitter of commercial vehicle attachments and equipment. The Company's portfolio includes snow and ice management attachments sold under the BLIZZARD, FISHER, HENDERSON, SNOWEX, and WESTERN brands, turf care equipment under the TURFEX brand, and industrial maintenance equipment under the SWEEPEX brand. The Company's portfolio also includes the upfit of attachments and storage solutions under the HENDERSON brand, and the DEJANA brand and its related sub-brands. The Company also leases fifteen manufacturing upfit and service facilities located in Iowa, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, and Rhode Island. The Company conducts business in two segments: Work Truck Attachments and Work Truck Solutions.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.